Canzon Israel Ltd

TA:CNZN Israel Drug Manufacturers - Specialty & Generic
Market Cap
$1.66 Million
ILA617.82 Million ILA
Market Cap Rank
#43984 Global
#430 in Israel
Share Price
ILA150.20
Change (1 day)
-6.13%
52-Week Range
ILA54.00 - ILA200.00
All Time High
ILA345000.00
About

Canzon Israel Ltd focuses on investing and managing projects in the field of initiating construction for residential and commercial purposes in Portugal. The company was formerly known as User Trend Ltd and changed its name into Canzon Israel Ltd in June 2019. Canzon Israel Ltd was incorporated in 1999 and is based in Tel Aviv, Israel.

Canzon Israel Ltd (CNZN) - Net Assets

Latest net assets as of June 2024: ILA3.58 Million ILA

Based on the latest financial reports, Canzon Israel Ltd (CNZN) has net assets worth ILA3.58 Million ILA as of June 2024.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA4.53 Million) and total liabilities (ILA956.00K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets ILA3.58 Million
% of Total Assets 78.91%
Annual Growth Rate -9.76%
5-Year Change -81.79%
10-Year Change -43.31%
Growth Volatility 37.19

Canzon Israel Ltd - Net Assets Trend (2012–2023)

This chart illustrates how Canzon Israel Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Canzon Israel Ltd (2012–2023)

The table below shows the annual net assets of Canzon Israel Ltd from 2012 to 2023.

Year Net Assets Change
2023-12-31 ILA4.23 Million -54.43%
2022-12-31 ILA9.28 Million -24.38%
2021-12-31 ILA12.27 Million -21.95%
2020-12-31 ILA15.72 Million -32.29%
2019-12-31 ILA23.22 Million +17822.14%
2018-12-31 ILA-131.00K -125.14%
2017-12-31 ILA521.00K -91.88%
2016-12-31 ILA6.42 Million +3.38%
2015-12-31 ILA6.21 Million -16.80%
2014-12-31 ILA7.46 Million -32.35%
2013-12-31 ILA11.02 Million -15.74%
2012-12-31 ILA13.08 Million --

Equity Component Analysis

This analysis shows how different components contribute to Canzon Israel Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 4769800000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2023)

Component Amount Percentage
Other Comprehensive Income ILA3.84 Million 90.92%
Other Components ILA80.78 Million 1910.50%
Total Equity ILA4.23 Million 100.00%

Canzon Israel Ltd Competitors by Market Cap

The table below lists competitors of Canzon Israel Ltd ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Canzon Israel Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2022 to 2023, total equity changed from 8,803,000 to 4,228,000, a change of -4,575,000 (-52.0%).
  • Net loss of 4,743,000 reduced equity.
  • Other comprehensive income increased equity by 118,000.
  • Other factors increased equity by 50,000.

Equity Change Factors (2022 to 2023)

Factor Impact Contribution
Net Income ILA-4.74 Million -112.18%
Other Comprehensive Income ILA118.00K +2.79%
Other Changes ILA50.00K +1.18%
Total Change ILA- -51.97%

Book Value vs Market Value Analysis

This analysis compares Canzon Israel Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 146.11x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has increased from 14.30x to 146.11x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2019-12-31 ILA10.50 ILA150.20 x
2020-12-31 ILA4.04 ILA150.20 x
2021-12-31 ILA2.99 ILA150.20 x
2022-12-31 ILA2.14 ILA150.20 x
2023-12-31 ILA1.03 ILA150.20 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Canzon Israel Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -112.18%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -4790.91%
  • • Asset Turnover: 0.02x
  • • Equity Multiplier: 1.24x
  • Recent ROE (-112.18%) is below the historical average (-45.03%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2012 -5.14% -6.32% 0.38x 2.16x ILA-1.51 Million
2013 -8.05% -6.59% 0.81x 1.51x ILA-1.81 Million
2014 -33.77% -25.14% 1.06x 1.27x ILA-3.17 Million
2015 -22.28% -10.74% 1.35x 1.54x ILA-1.87 Million
2016 4.61% 2.11% 1.43x 1.53x ILA-327.80K
2017 24.40% 3.00% 6.45x 1.26x ILA72.00K
2018 0.00% 0.00% 0.00x 0.00x ILA-427.90K
2019 -241.15% -233275.00% 0.00x 1.06x ILA-58.31 Million
2020 -78.36% -4446.93% 0.02x 1.07x ILA-13.89 Million
2021 -25.33% -5267.80% 0.00x 1.07x ILA-4.33 Million
2022 -43.12% -318.46% 0.12x 1.12x ILA-4.68 Million
2023 -112.18% -4790.91% 0.02x 1.24x ILA-5.17 Million

Industry Comparison

This section compares Canzon Israel Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $17,525,530
  • Average return on equity (ROE) among peers: -47.13%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Canzon Israel Ltd (CNZN) ILA3.58 Million -5.14% 0.27x $18.43K
Intercure (INCR) $24.07 Million 1.10% 0.15x $367.38K
Nextage Therapeutics Ltd (NXTG) $-1.65 Million 0.00% 0.00x $70.01K
Rekah Pharmaceutical Industry Ltd (REKA) $48.86 Million 18.05% 3.13x $385.28K
Seach Medical Group Ltd (SEMG) $-362.00K 0.00% 0.00x $278.78K
Together Startup Network Ltd (TGTR) $1.19 Million -32.91% 2.27x $124.45K
Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) $33.04 Million -269.00% 1.32x $75.63K